Alicia Jenkins to Diabetes Complications
This is a "connection" page, showing publications Alicia Jenkins has written about Diabetes Complications.
Connection Strength
0.555
-
Diabetes, metabolic disease, and telomere length. Lancet Diabetes Endocrinol. 2021 02; 9(2):117-126.
Score: 0.159
-
Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: a hypothesis-generating prospective study of cardiovascular events in T1D. J Lipid Res. 2019 08; 60(8):1432-1439.
Score: 0.144
-
Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study. Diabetologia. 2015 Sep; 58(9):2035-44.
Score: 0.109
-
Association between PON 1 polymorphisms, PON activity and diabetes complications. J Diabetes Complications. 2006 Sep-Oct; 20(5):322-8.
Score: 0.059
-
Foot problems and foot care practices in diabetes. A survey of public and private diabetes clinics affiliated with a university hospital. J S C Med Assoc. 2002 Dec; 98(8):305-10.
Score: 0.046
-
LDL-containing immune complexes in the DCCT/EDIC cohort: associations with lipoprotein subclasses. J Diabetes Complications. 2011 Mar-Apr; 25(2):73-82.
Score: 0.019
-
Lipid treatment guidelines and cardiovascular risk for Aboriginal people in Central Australia. Med J Aust. 2009 May 18; 190(10):552-6.
Score: 0.018